The book provides a concise much-needed update of beta-blockers use cardiovascular area (particularly hypertension and heart failure). It will uncover the clinical inaccuracies of how the UK NICE Committee have “got it wrong” in their recent pronouncements on BBs and hypertension. Beta-blockers (BBs) are a large and important family of therapeutic agents with primary use is in cardiovascular medicine. The therapeutic areas that BB covers include: Ischemic Heart Disease, Hypertension, Heart Failure and Arrhythmias.